DEFINING AND MEASURING THE COSTS OF THE HIV EPIDEMIC TO BUSINESS FIRMS
Saved in:
FARNHAM, P.G., DEFINING AND MEASURING THE COSTS OF THE HIV EPIDEMIC TO BUSINESS FIRMS. PUBLIC HEALTH REPORTS, Vol. 109, no. 3 (1994), p. 311-318.
Ref.
38340
Location:
SIIS R.945
Palabras clave:
Coste, Gasto social, Sida, Tratamiento
Coste, Gasto social, Sida, Tratamiento
Similar Items: DEFINING AND MEASURING THE COSTS OF THE HIV EPIDEMIC TO BUSINESS FIRMS
- COUNSELING AND TESTING FOR HIV PREVENTION: COSTS, EFFECTS, AND COST-EFFECTIVENESS OF MORE RAPID SCREENING TESTS
- HIV INFECTION TREATMENT COSTS UNDER MEDICAID IN MICHIGAN
- COST EFFECTIVENESS OF "HAART". THE SOCIAL CONSEQUENCES FOR HIV / AIDS CARE
- DEFINING THE CHALLENGES OF PROVIDING LONG-TERM CARE: THE CASE OF THE NURSING HOME INDUSTRY'S RESPONSE TO THE AIDS EPIDEMIC
- PREVENTING PERINATAL TRANSMISSION OF HIV - COSTS AND EFFECTIVENESS OF A RECOMMENDED INTERVENTION
- HOMOSEXUAL AND BISEXUAL MEN'S COPING WITH THE AIDS EPIDEMIC: QUALITATIVE INTERVIEWS WITH 10 NON-HIV-TESTED HOMOSEXUAL AND BISEXUAL MEN